within Pharmacolibrary.Drugs.ATC.R;

model R02AA14
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 1.9999999999999998e-05,
    adminDuration  = 600,
    adminMass      = 250 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.06,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R02AA14</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Oxyquinoline (also known as 8-hydroxyquinoline) is an aromatic organic compound with fungistatic and bacteriostatic properties, historically used as an antiseptic for oral and topical applications. It is categorized as an antiseptic within the ATC code R02AA14. Currently, its use as a medicinal product is limited and it is largely discontinued in many countries due to safety concerns and the availability of safer alternatives.</p><h4>Pharmacokinetics</h4><p>No pharmacokinetic parameters are reported in existing literature or regulatory documents for oxyquinoline in humans. Below parameters are rough estimates for an average adult healthy population, based on similarity to other quinoline derivatives.</p><h4>References</h4><ol><li><p>Mao, X, &amp; Schimmer, AD (2008). The toxicology of Clioquinol. <i>Toxicology letters</i> 182(1-3) 1–6. DOI:<a href=&quot;https://doi.org/10.1016/j.toxlet.2008.08.015&quot;>10.1016/j.toxlet.2008.08.015</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18812216/&quot;>https://pubmed.ncbi.nlm.nih.gov/18812216</a></p></li><li><p>Bareggi, SR, &amp; Cornelli, U (2012). Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. <i>CNS neuroscience &amp; therapeutics</i> 18(1) 41–46. DOI:<a href=&quot;https://doi.org/10.1111/j.1755-5949.2010.00231.x&quot;>10.1111/j.1755-5949.2010.00231.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21199452/&quot;>https://pubmed.ncbi.nlm.nih.gov/21199452</a></p></li><li><p>Bondiolotti, G, et al., &amp; Bareggi, SR (2007). Pharmacokinetics and distribution of clioquinol in golden hamsters. <i>The Journal of pharmacy and pharmacology</i> 59(3) 387–393. DOI:<a href=&quot;https://doi.org/10.1211/jpp.59.3.0008&quot;>10.1211/jpp.59.3.0008</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17331342/&quot;>https://pubmed.ncbi.nlm.nih.gov/17331342</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R02AA14;
